Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
These directly deplete GSH, causing disruption of mitochondrial Ca 2 homeostasis and inhibition of electron transport chain complexes
10.1111/apt.12147 99
Unless you're microdosing, 2 mL per vial is a solid rule of thumb
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Retatrutide (10 mg) is listed for laboratory research use only
Other medical professionals trained in administering this drug can also do it
)
US$ 29.11
US$ 21.57
US$ 25.88
US$ 21.90
